Abacavir
- Product NDC
- 64380-717
- 11-digit product format
- 643800717
- Labeler code
- 64380
- Product ID
- 64380-717_97ce679d-9af1-4a83-a823-09aefb34665a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA091050
- Marketing category
- ANDA
- Marketing start
- 2016-10-28
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64380-717-01 | 64380071701 | 60 TABLET in 1 BLISTER PACK (64380-717-01) | 60 tablet | 2016-10-28 | 0000-00-00 | No | No | Current |
| 64380-717-03 | 64380071703 | 60 TABLET in 1 BOTTLE (64380-717-03) | 60 tablet | 2016-10-28 | 0000-00-00 | No | No | Current |